Publicaciones en las que colabora con Domingo Francisco Javier Díez Martínez (82)

2023

  1. Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides

    JACC: Heart Failure, Vol. 11, Núm. 1, pp. 58-72

2020

  1. Burden and challenges of heart failure in patients with chronic kidney disease. A call to action

    Nefrologia, Vol. 40, Núm. 3, pp. 223-236

  2. Erratum: G protein–coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity (Diabetes, (2010) 59, (2407-2417), 10.2337/db10-0771)

    Diabetes

2019

  1. Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both?

    American Journal of Hypertension

  2. The renal immune-inflammatory component of arterial hypertension: Emerging therapeutic strategies

    Cardiovascular Research, Vol. 115, Núm. 4, pp. 696-698

2018

  1. Unraveling new mechanisms of renal fibrosis with potential therapeutic implications

    Hypertension

2017

  1. Epicardial Adipose Tissue in the General Middle-aged Population and Its Association With Metabolic Syndrome

    Revista Espanola de Cardiologia, Vol. 70, Núm. 4, pp. 254-260

  2. Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men

    Free Radical Research, Vol. 51, Núm. 4, pp. 389-396

  3. Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites

    Scientific Reports, Vol. 7

2015

  1. Targeting γ-secretases protect against angiotensin II-induced cardiac hypertrophy

    Journal of Hypertension

2014

  1. Association of Phagocytic NADPH Oxidase Activity With Hypertensive Heart Disease: A Role for Cardiotrophin-1?

    Hypertension, Vol. 63, Núm. 3, pp. 468-474

2013

  1. A synthetic peptide from transforming growth factor-β1 Type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

    Antioxidants and Redox Signaling, Vol. 19, Núm. 14, pp. 1607-1618

  2. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients

    Journal of Hypertension, Vol. 31, Núm. 3, pp. 587-594

  3. Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis

    Clinical Science, Vol. 125, Núm. 6, pp. 291-300

2012

  1. Activated protein C: Reasons to believe

    Journal of Thrombosis and Haemostasis

  2. The influence of obesity on the assessment of carotid intima-media thickness

    Journal of Clinical Ultrasound, Vol. 40, Núm. 8, pp. 479-485

2011

  1. Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure

    Journal of Hypertension, Vol. 29, Núm. 5, pp. 876-883

  2. The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes

    Frontiers in Bioscience - Elite, Vol. 3 E, Núm. 4, pp. 1467-1474

2010

  1. Association between metabolic syndrome or its components and asymptomatic cardiovascular disease in the RIVANA-study

    Atherosclerosis, Vol. 211, Núm. 2, pp. 612-617

  2. Corrigendum to "Preliminary characterisation of the promoter of the human p22phox gene: Identification of a new polymorphism associated with hypertension" [FEBS Lett. 542 (2003) 27-31]

    FEBS Letters